Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection

British Journal of Ophthalmology

Volumn 83, Issue 12, 1999, Pages 1348-1352

  Hudde, T ^a   Minassian, D C ^b   Larkin, D F P ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CORTICOSTEROID THERAPY; EYE DISEASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCONJUNCTIVAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0032695003     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.12.1348     Document Type: Article

References (19)

1. Williams KA, Muehlberg SM, Lewis RF, et al. Long-term outcome in corneal allotransplantation. The Australian Corneal Graft Registry. Transplant Proc 1997;29:983.
2. Coster DJ, Williams KA. Immunosuppression for corneal transplantation and treatment of graft rejection. Transplant Proc 1989;21:3125-6.
3. Alldredge OC, Krachmer JH. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 1981;99:599-604.
4. Gibbs DC, Batchelor JR, Werb A, et al. The influence of tissue-type compatibility on the fate of full-thickness corneal grafts. Trans Ophthalmol Soc UK 1974;94:101-26.
5. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994; 101:1536-47.
6. Boisjoly HM, Roy R, Bernard PM, er al. Association between corneal allograft reactions and HLA compatibility. Ophthalmology 1990;97:1689-98.
7. Boisjoly HM, Bernard PM, Dube I, et al. Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection. Am J Ophthalmol 1989;107:647-54.
8. The Collaborative Corneal Transplantation Studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992;110:1392-403.
9. Kuchle M, Nguyen NX, Naumann GO. Aqueous flare following penetrating keratopiasty and in corneal graft rejection. Arch Ophthalmol 1994;112:354-8.
10. Hill JC, Maske R, Watson PG. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report. Eye 1991;5:420-4.
11. Rinne JR, Stulting RD. Current practices in the prevention and treatment of corneal graft rejection. Cornea 1992;11: 326-8.
12. Hill JC, Maske R, Watson P. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. Ophthalmology 1991;98:329-33.
13. Hill JC, Ivey A. Corticosteroids in corneal graft rejection: double versus single pulse therapy. Cornea 1994;13:383-8.
14. Pleyer U, Steuhl KP, Weidle EG, et al. Corneal graft rejection: incidence, manifestation, and interaction of clinical subtypes. Transplant Proc 1992;24:2034-7.
15. Khodadoust AA, Silverstein AM, Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol 1969;8:180-95.
16. Musch DC, Schwartz AE, Fitzgerald-Shelton K, et al. The effect of allograft rejection after penetrating keratopiasty on central endothelial cell density. Am J Ophthalmol 1991;111: 739-12.
17. Bourne WM, Hodge DO, Nelson LR. Corneal endothelium five years after transplantation. Am J Ophthatmol 1994;118: 185-96.
18. Ing JJ, Ing HH, Nelson LR, et al. Ten-year postoperative results of penetrating keratopiasty. Ophthalmology 1998; 105:1855-65.
19. Harper CL, Boulton ME, Marcyniuk B, et al. Endothelial viability of organ cultured corneas following penetrating keratopiasty. Eye 1998;12:834-8.